Washington, D.C. (July 3, 2018) -- Senate Judiciary Committee Chairman Charles Grassley and Senator Amy Klobuchar have asked the Federal Trade Commission to investigate whether makers of biologic medicines are using practices that hinder or delay biosimilars from entering the market....